Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2013ImmunoTargets and TherapyOpen Access

Update on immunopathogenesis and immunotherapy in multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBernhard HemmerBroad InstituteSSelter

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hemmer et al. (2013) studied this question.

synapsesocial.com/papers/6a950d7e2fdd6c151ff21c0dhttps://doi.org/10.2147/itt.s31813
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome2007 · 44 citations
  2. 2Mechanisms of immunomodulation by glatiramer acetate2000 · 161 citations
  3. 3Axonal damage in acute multiple sclerosis lesions1997 · 1,548 citations
  4. 4Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis2010 · 2,216 citations
  5. 5Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 · 1,349 citations